Semin Thromb Hemost 2007; 33(1): 075-079
DOI: 10.1055/s-2006-958465
Copyright © 2007 by Thieme Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Prostasomes, Angiogenesis, and Tissue Factor

George H. Delves1 , Alistair B. Stewart2 , Alan J. Cooper1 , Bashir A. Lwaleed3
  • 1School of Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
  • 2Pyrah Department of Urology, St. James' University Hospital Leeds, Leeds, United Kingdom
  • 3Department of Urology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom
Further Information

Publication History

Publication Date:
29 January 2007 (online)

ABSTRACT

Prostasomes are membrane-bound secretory vesicles produced by prostatic epithelial cells. They are known to carry many proteins, including tissue factor, and have membranes unusually rich in cholesterol and sphingomyelin. Prostasomes have well-documented effects on fertility, promoting sperm motility, stabilizing the acrosome reaction, and facilitating immunosuppression. This article reviews the evidence of the effects of prostasomes on in vitro angiogenesis assays, and the mechanism by which these effects occur. Seminal prostasomes seem to inhibit angiogenesis, whereas the equivalent particles released by malignant prostate cells promote angiogenesis. In both cases, the effects seem preserved after heat treatment to denature the protein content, suggesting an important role for lipid transfer, in particular, transfer of sphingomyelin.

REFERENCES

  • 1 Ronquist G, Hedström M. Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A.  Biochim Biophys Acta. 1977;  483 483-486
  • 2 Ronquist G, Brody I, Gottfries A, Stegmayr B A. Mg2 + and Ca2 + -stimulated adenosine triphosphatase in human prostatic fluid.  Andrologia. 1978;  10 261-272 (part I), 427-433 (part II)
  • 3 Ronquist G, Brody I. The prostasome: its secretion and function in man.  Biochim Biophys Acta. 1985;  822 203-218
  • 4 Arienti G, Carlini E, Saccardi C, Palmerini C A. Fatty acid pattern of human prostasome lipid.  Arch Biochem Biophys. 1998;  358 391-395
  • 5 Arienti G, Saccardi C, Carlini E, Verdacchi R, Palmerini C A. Distribution of lipid and protein in human semen fractions.  Clin Chim Acta. 1999;  289 111-120
  • 6 Kelly R W, Holland P, Skibinski G et al.. Extracellular organelles (prostasomes) are immunosuppressive components of human semen.  Clin Exp Immunol. 1991;  86 550-556
  • 7 Carlini E, Palmerini A, Cosmi E V, Arienti G. Fusion of sperm with prostasomes: effects on membrane fluidity.  Arch Biochem Biophys. 1997;  343 6-12
  • 8 Saez F, Motta C, Boucher D, Grizard G. Prostasomes inhibit the NADPH oxidase activity of human neutrophils.  Mol Hum Reprod. 2000;  6 883-891
  • 9 Utleg A G, Yi E C, Xie T et al.. Proteomic analysis of human prostasomes.  Prostate. 2003;  56 150-161
  • 10 Arienti G, Carlini E, Nicolucci A, Cosmi E V, Santi F, Palmerini C A. The motility of human spermatozoa as influenced by prostasomes at various pH levels.  Biol Cell. 1999;  91 51-54
  • 11 Palmerini C A, Saccardi C, Carlini E, Fabiani R, Arienti G. Fusion of prostasomes to human spermatozoa stimulates the acrosome reaction.  Fertil Steril. 2003;  80 1181-1184
  • 12 Fernández J A, Heeb M J, Radtke K P, Griffin J H. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor.  Biol Reprod. 1997;  56 757-763
  • 13 Stewart A B, Anderson W, Delves G, Lwaleed B A, Birch B, Cooper A. Prostasomes: a role in prostatic disease?.  BJU Int. 2004;  94 985-989
  • 14 Ronquist G, Nilsson B O. The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth.  Prostate Cancer Prostatic Dis. 2004;  7 21-31
  • 15 Hanahan D, Weinberg R A. The hallmarks of cancer.  Cell. 2000;  100 57-70
  • 16 Tannock I F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.  Br J Cancer. 1968;  22 258-273
  • 17 Hepburn P J, Griffiths K, Harper M E. Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro.  Prostate. 1997;  33 123-132
  • 18 Weingartner K, Ben-Sasson S A, Stewart R, Richie J P, Riedmiller H, Folkman J. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment.  J Urol. 1998;  159 465-470
  • 19 Joseph I B, Nelson J B, Denmeade S R, Isaacs J T. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.  Clin Cancer Res. 1997;  3 2507-2511
  • 20 Levine A C, Liu X H, Greenberg P D et al.. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.  Endocrinology. 1998;  139 4672-4678
  • 21 Zhong H, De Marzo A M, Laughner E et al.. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.  Cancer Res. 1999;  59 5830-5835
  • 22 Fortier A H, Nelson B J, Grella D K, Holaday J W. Antiangiogenic activity of prostate-specific antigen.  J Natl Cancer Inst. 1999;  91 1635-1640
  • 23 Heidtmann H H, Nettelbeck D M, Mingels A, Jager R, Welker H G, Kontermann R E. Generation of angiostatin-like fragments from plasminogen by prostate specific antigen.  Br J Cancer. 1999;  81 1269-1273
  • 24 Weidner N, Carroll P R, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.  Am J Pathol. 1993;  143 401-409
  • 25 Fregene T A, Khanuja P S, Noto A C et al.. Tumor-associated angiogenesis in prostate cancer.  Anticancer Res. 1993;  13 2377-2382
  • 26 Borre M, Offersen B V, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.  Br J Cancer. 1998;  78 940-944
  • 27 Brawer M K, Deering R E, Brown M, Preston S D, Bigler S A. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity.  Cancer. 1994;  73 678-687
  • 28 Silberman M A, Partin A W, Veltri R W, Epstein J I. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.  Cancer. 1997;  79 772-779
  • 29 Strohmeyer D, Rossing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.  Prostate. 2000;  42 26-33
  • 30 Vartanian R K, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.  Lab Invest. 1995;  73 844-850
  • 31 Abdulkadir S A, Carvalhal G F, Kaleem Z et al.. Tissue factor expression and angiogenesis in human prostate carcinoma.  Hum Pathol. 2000;  31 443-447
  • 32 Versteeg H H, Peppelenbosch M P, Spek C A. Tissue factor signal transduction in angiogenesis.  Carcinogenesis. 2003;  24 1009-1013
  • 33 Bugge T H, Xiao Q, Kombrinck K W et al.. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.  Proc Natl Acad Sci U S A. 1996;  93 6258-6261
  • 34 Toomey J R, Kratzer K E, Lasky N M, Stanton J J, Broze Jr G J. Targeted disruption of the murine tissue factor gene results ion embryonic lethality.  Blood. 1996;  88 1583-1587
  • 35 Rosen E D, Chan J C, Idusogie E et al.. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.  Nature. 1997;  390 290-294
  • 36 Rosen E D, Zhong L, Cornelissen I, Martin A, Castellino F J. Coagulation factor VII is required for embryonic development in mice.  Blood. 2001;  98 3424(Abst)
  • 37 Koomagi R, Volm M. Tissue-factor expression in human nonsmall-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.  Int J Cancer. 1998;  79 19-22
  • 38 Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.  Br J Cancer. 2000;  82 1967-1973
  • 39 Shoji M, Hancock W W, Abe K et al.. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.  Am J Pathol. 1998;  152 399-411
  • 40 Zhang Y, Deng Y, Luther T et al.. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.  J Clin Invest. 1994;  94 1320-1327
  • 41 Hicks J A, Anderson W M, Lwaleed B A, Cooper A J, Holmes S AV. Do CD142 carrying prostatic exosomes promote angiogenesis?.  BJU Int. 2005;  95(suppl 5) 81(Abst)
  • 42 Delves G H, Stewart A B, Lwaleed B A, Cooper A J. In vitro inhibition of angiogenesis by prostasomes.  Prostate Cancer Prostatic Dis. 2005;  8 174-178
  • 43 Arienti G, Polci A, Carlini E, Palmerini C A. Transfer of CD26/dipeptidyl peptidase (E.C.3.5.4.4.) from prostasomes to sperm.  FEBS Lett. 1997;  410 343-346
  • 44 Arienti G, Carlini E, Verdacchi R, Palmerini C A. Transfer of aminopeptidase activity from prostasomes to sperm.  Biochim Biophys Acta. 1997;  1336 269-274
  • 45 Delves G H, Goyal A, Lwaleed B A, Cooper A J. Seminal prostasomes inhibit the angiogenesis activity of rat aortic rings.  Prostate Cancer Prostatic Dis. 2006;  9(4) 444-447
  • 46 Kim C W, Lee H M, Lee T H, Kang C, Kleinman H K, Gho Y S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.  Cancer Res. 2002;  62 6312-6317
  • 47 Carlsson L, Nilsson O, Larsson A, Stridsberg M, Sahlen G, Ronquist G. Characteristics of human prostasomes isolated from three different sources.  Prostate. 2003;  54 322-330
  • 48 Nilsson B O, Lennartsson L, Carlsson L, Nilsson S, Ronquist G. Expression of prostasome-like granules by the prostate cancer cell lines PC3, Du145, and LnCaP grown in monolayer.  Ups J Med Sci. 1999;  104 199-206
  • 49 Nilsson B O, Egevard L, Jin M, Ronquist G, Busch C. Distribution of prostasomes in neoplastic epithelial prostate cells.  Prostate. 1999;  39 36-40
  • 50 Wang J, Lundqvist M, Carlsson L, Nilsson O, Lundkvist O, Ronquist G. Prostasome-like granules from the PC-3 prostate cancer cell line increase the motility of washed human spermatozoa and adhere to the sperm.  Eur J Obstet Gynecol Reprod Biol. 2001;  96 88-97
  • 51 Abrahamsson P A, Falkmer S, Falt K, Grimelius L. The course of neuroendocrine differentiation in prostatic adenocarcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”.  Pathol Res Pract. 1989;  185 373-380
  • 52 Schmid K W, Helpap B, Totsch M et al.. Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic, and neoplastic prostate.  Histopathology. 1994;  24 233-239
  • 53 Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview.  Clin Chem. 2003;  49 32-40
  • 54 Matsubara K, Matsumoto H, Mizushina Y et al.. Inhibitory effect of glycolipids from spinach on in vitro and ex vivo angiogenesis.  Oncol Rep. 2005;  14 157-160

Dr. Bashir A Lwaleed

Department of Urology, Central Block, E Level, West Wing, Mailpoint 67, Southampton University Hospitals

Southampton, Tremona Road, SO16 6YD, United Kingdom

Email: bashir@soton.ac.uk